Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

1(16.7%)

Phase 2

1(16.7%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 3(1)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05973110Not ApplicableRecruiting

Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis

Role: collaborator

NCT06431386Not ApplicableTerminated

Behavioural Activation Therapy and Esketamine for Resistant Depression

Role: lead

NCT05427500Phase 3Enrolling By Invitation

Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder

Role: lead

NCT06809166Phase 4Recruiting

Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity

Role: lead

NCT06891300Phase 2Recruiting

Understanding and Treating Suicidal Ideation With Ketamine

Role: lead

NCT04110041Not ApplicableRecruiting

Effects of Aerobic Exercise Intensity on Clinical & Neural Outcomes in Depressed Youth

Role: lead

NCT06159322Unknown

Characterizing Response to Antipsychotics in Schizophrenia

Role: collaborator

NCT04369690Unknown

The Psychological, Social, and Economic Impacts of COVID-19

Role: collaborator

All 8 trials loaded